Episode Details

Malaysia's Medical Device Authority (MDA) is mandating fully online submissions for all medical device product classification applications starting August 1, 2026. This episode details the transition to the new Product Classification Application System (PCAS), explains the impact on manufacturers seeking market access in Malaysia, and provides practical steps for regulatory teams to prepare for this digital-only process to avoid delays. Key Questions: - What is the new requirement from Malaysia's Medical Device Authority (MDA)? - When does the mandatory online submission for product classification take effect? - Which new system must manufacturers use for these submissions? - How does this change impact the market access process for medical devices in Malaysia? - Who is affected by this regulatory shift? - What are the practical steps regulatory teams should take to prepare for this transition? - Why is it important to update internal procedures and documentation now? - What should you consider when planning your submission timeline using the new PCAS system? Sources: - https://www.pure-global.com/news/malaysia-mda-online-product-classification-2026 How Pure Global can help: Pure Global provides end-to-end regulatory consulting for MedTech and IVD companies, accelerating global market access. We develop efficient regulatory strategies, act as your local representative in over 30 markets, and use advanced AI to compile and manage technical dossiers for submission. Our experts help you navigate complex requirements like Malaysia's new PCAS system, ensuring your submissions are compliant and timely. By partnering with us, you can streamline your registration process and focus on your core business. Contact us at info@pureglobal.com, visit https://pureglobal.com, or explore our free AI tools and device database at https://pureglobal.ai to learn more.